Skip to main content

Practice Management

Practice Management
The Better Quality Information to Improve Care for Medicare Beneficiaries Project: Exploring Approaches to Physician Performance Measurement
Aucha Prachanronarong, MHS
Stakeholder Perspective
Medicare's Evolution from Passive Payer to Value-Driven Purchaser of Healthcare
by Kip Piper, MA, FACHE
Read More
Practice Management
e-Prescribing: Stakeholders Collaborating to Reduce Medication Errors
Read More
Practice Management
What Changes Can Your Health Plan Expect from the New Administration?
Stakeholder Perspective
Health Policy in the New Administration
by Joseph R. Antos, PhD
Read More
Practice Management
Patient Cost-Sharing on the Rise: Results from the Benefit Design Index
Melinda C. Haren, RN, Kirk McConnell
Stakeholder Perspective
Cost-Shifting—Where Does It Stop?
by David Williams
Read More
Practice Management
Employer-Based Health Initiative: Impact on Employees? Cardiovascular Outcomes
Gene Reeder, RPh, PhD, Christine H. Divers, PhD, Del Deem, Becky J. Cherney, Gaye Fortner, RN, BSN, MSM, Louise Y. Probst
Stakeholder Perspective
Employer-Based Wellness Initiatives: Lifestyle Modifications Insufficient in Employees at High Risk for Cardiovascular Disease
by Charles E. Collins, Jr., MS, MBA
Read More
Practice Management
Will 2009 Usher in the Era of Biogenerics?
Dalia Buffery, MA, ABD
Read More
Practice Management
Prescription Copay Reduction Program for Diabetic Employees: Impact on Medication Compliance and Healthcare Costs and Utilization
Kavita V. Nair, PhD, Kerri Miller, PharmD, BCPS, Joseph Saseen, PharmD, FCCP, BCPS, Pamela Wolfe, MS, Richard Read Allen, MS, Jinhee Park, CPhil, Ma, MS
Stakeholder Perspective
Improved Clinical Outcomes the True Value of Copay Reductions for Diabetic Employees, Despite Increased Overall Costs
by Geoffrey P. Cole, MD, MBA
Read More
Practice Management
Recent Slowdown in National Health Expenditures Attributed to Growing Use of Generics
Dalia Buffery, MA, ABD
Read More
Practice Management
Focus on Lowest Net Cost Drug Reduces Costs for Patients, Plan Sponsors
Dana H. Felthouse, MBA
Read More
Practice Management
Erythropoiesis-Stimulating Agents in a Meta-Stable State: Guidelines, Economics, and Policy in Flux
Stakeholder Perspective
The Clinical and Economic Complexity of Biologics
by F. Randy Vogenberg, PhD, FASHP
Read More
Page 28 of 32
Results 271 - 280 of 318